SELLAS Life Sciences
21 hedge funds and large institutions have $5.37M invested in SELLAS Life Sciences in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
229% more capital invested
Capital invested by funds: $1.63M → $5.37M (+$3.74M)
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
50% more funds holding
Funds holding: 14 → 21 (+7)
1.33% more ownership
Funds ownership: 6.52% → 7.85% (+1.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.77M |
| 2 |
EH
Equitable Holdings
New York
|
+$136K |
| 3 |
VF
Virtu Financial
New York
|
+$77.8K |
| 4 |
Jane Street
New York
|
+$77.5K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$65K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$567K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$106K |
| 3 |
MML Investors Services
Springfield,
Massachusetts
|
-$29K |
| 4 |
Morgan Stanley
New York
|
-$4.74K |
SLS Hedge Fund Activity: Q4 2020 in Review
21 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in SELLAS Life Sciences (SLS) for Q4 2020, worth a combined $5.37M — up 229% from $1.63M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new SLS positions and 2 closed out — a net gain of 7 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.77M. The largest seller was Worth Venture Partners, exiting entirely with an estimated $567K sold.
- 21 institutional investors held SELLAS Life Sciences (SLS) as of Q4 2020, up from 14 in Q3 2020.
- Funds reported $5.37M of SELLAS Life Sciences stock for Q4 2020, up 229% quarter-over-quarter.
- 9 funds opened new SELLAS Life Sciences positions in Q4 2020 and 2 closed out, a net change of +7 holders.
- The largest SELLAS Life Sciences buyer in Q4 2020 was Vanguard Group, an estimated $1.77M added.
- The largest SELLAS Life Sciences seller in Q4 2020 was Worth Venture Partners, an estimated $567K sold.
Based on aggregated 13F filings for Q4 2020.